These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16483497)

  • 1. [Advance and current status of exemestane and androstadienes in the treatment of breast cancer].
    Wang LP; Shen KW; Shan ZZ
    Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):764-6. PubMed ID: 16483497
    [No Abstract]   [Full Text] [Related]  

  • 2. Exemestane or tamoxifen?
    Ueda M; Toji E; Noda S
    Lancet; 2007 May; 369(9573):1600; author reply 1600-1. PubMed ID: 17499595
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term outcomes of aromatase inhibition for breast cancer.
    Toi M
    Lancet Oncol; 2008 Jan; 9(1):8-10. PubMed ID: 18177815
    [No Abstract]   [Full Text] [Related]  

  • 4. Tamoxifen therapy for patients with breast cancer.
    Litton J; Buzdar A; Mac Gregor MC; Gonzalez-Angulo A; Hortobagyi G
    Lancet; 2013 Jun; 381(9883):2077-8. PubMed ID: 23769223
    [No Abstract]   [Full Text] [Related]  

  • 5. Controversies in endocrine treatment: effective utilization of steroidal and nonsteroidal aromatase inhibitors: now and in the future. Forward.
    Aapro M
    Anticancer Drugs; 2008 Mar; 19 Suppl 2():S1. PubMed ID: 18337639
    [No Abstract]   [Full Text] [Related]  

  • 6. Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
    Jahanzeb M
    Clin Ther; 2007 Aug; 29(8):1535-47. PubMed ID: 17919537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New strategies against breast carcinoma. To outwit the resistance tendency of tumor cells].
    Jakesz R
    MMW Fortschr Med; 2005 Mar; 147(10):8. PubMed ID: 15803774
    [No Abstract]   [Full Text] [Related]  

  • 8. Sequential treatment with exemestane and non-steroidal aromatase inhibitors in advanced breast cancer.
    Bertelli G; Garrone O; Merlano M; Occelli M; Bertolotti L; Castiglione F; Pepi F; Fusco O; Del Mastro L; Leonard RC
    Oncology; 2005; 69(6):471-7. PubMed ID: 16410685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review.
    Eisen A; Trudeau M; Shelley W; Messersmith H; Pritchard KI
    Cancer Treat Rev; 2008 Apr; 34(2):157-74. PubMed ID: 18164821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma: the M. D. Anderson Cancer Center evidence-based approach.
    Morandi P; Rouzier R; Altundag K; Buzdar AU; Theriault RL; Hortobagyi G
    Cancer; 2004 Oct; 101(7):1482-9. PubMed ID: 15378476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination endocrine treatments unproven in breast cancer.
    Buzdar AU
    Lancet Oncol; 2013 Sep; 14(10):917-8. PubMed ID: 23902873
    [No Abstract]   [Full Text] [Related]  

  • 12. Switching to aromatase inhibitors in early breast cancer.
    Boccardo F; Rubagotti A
    Lancet; 2007 Feb; 369(9561):533-5. PubMed ID: 17307082
    [No Abstract]   [Full Text] [Related]  

  • 13. The biology of steroid hormones and endocrine treatment of breast cancer.
    Dowsett M; Folkerd E; Doody D; Haynes B
    Breast; 2005 Dec; 14(6):452-7. PubMed ID: 16198110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATAC trial update.
    Del Mastro L; Venturini M
    Lancet; 2005 Apr 2-8; 365(9466):1225; author reply 1225-6. PubMed ID: 15811447
    [No Abstract]   [Full Text] [Related]  

  • 15. Exemestane as first-line therapy in postmenopausal women with recurrent or metastatic breast cancer.
    Glück S
    Am J Clin Oncol; 2010 Jun; 33(3):314-9. PubMed ID: 19730353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: sequential tamoxifen-exemestane and upfront anastrozole.
    Skedgel C; Rayson D; Dewar R; Younis T
    Breast Cancer Res Treat; 2007 Mar; 101(3):325-33. PubMed ID: 16897433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen therapy for patients with breast cancer - Authors' reply.
    Davies C; Gray R; Pan H; Peto R;
    Lancet; 2013 Jun; 381(9883):2078-9. PubMed ID: 23769225
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer: some reasons to be hopeful.
    Lancet; 2007 Feb; 369(9561):531. PubMed ID: 17307079
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical evaluation of the use of exemestane as further hormonal therapy after nonsteroidal aromatase inhibitors in postmenopausal metastatic breast cancer patients.
    Carlini P; Michelotti A; Ferretti G; Ricci S; Giannarelli D; Pellegrini M; Cresti N; Di Cosimo S; Bria E; Papaldo P; Fabi A; Ruggeri EM; Milella M; Alimonti A; Salesi N; Cognetti F
    Cancer Invest; 2007 Mar; 25(2):102-5. PubMed ID: 17453821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of concurrent anastrozole on acute and late side effects of whole breast radiotherapy.
    Valakh V; Trombetta MG; Werts ED; Labban G; Khalid MK; Kaminsky A; Parda D
    Am J Clin Oncol; 2011 Jun; 34(3):245-8. PubMed ID: 20622644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.